TechniScan’s warm bath 3D breast imaging device featured as top emerging medical technology
CEO says the demand for breast diagnostics will grow with aging baby boomers
SALT LAKE CITY (August 11, 2010) – TechniScan (OTC BB: TSNI), was among the 25 top emerging medical technology companies featured today on Life Science Intelligence’s (LSI) investor presentation.
This online venue provides a timely release of the most promising emerging medical technology companies identified by LSI. The event provides detailed information on a select group of companies, including presentations (audio and slides), executive summaries, fund raising status, partnering status, and much more.
“This presentation places TechniScan and our warm bath, 3D breast imaging device among some of the most promising private and public medical technology companies today. It is a comprehensive and informative venue for investors to evaluate the latest technologies that have the potential to change the future of medicine,” said Dave Robinson, chief executive officer for TechniScan.
TechniScan’s warm bath, 3D breast imaging device is designed to capture three-dimensional images of the breast as a woman lies prone on a table and state-of-the-art ultrasound technology is used in a warm water tank to image the breast anatomy. Its revolutionary new method of imaging produces information and whole breast images that are not available with traditional reflection ultrasound or whole breast ultrasound systems presently on the market.
With the aging baby boomer population, the market segment for breast screening and diagnostic devices is expected to grow by 1.5 percent each year over the next twenty years. According to the National Cancer Institute, the highest percentage of breast cancer is found in women over the age of 65.
“Strictly considering the demographic growth projections for breast screening and diagnostics, there is a built in demand for our device. Couple this with the desire from women and radiologists for comfortable and more sophisticated tools to more accurately diagnose breast cancer, and we are very confident in the demand for our 3D breast imaging system,” said Robinson.
Unique to the ultrasound market, TechniScan’s revolutionary science employs transmission ultrasound in addition to standard reflection ultrasound to form its high-resolution, compounded 360-degree view of the breast in a natural uncompressed condition. The technology in protected by multiple patents.
Life Science Intelligence (LSI) delivers high quality market data and information to medical technology executives, entrepreneurs and investors. LSI produces its own information products and partners with select top tier information companies to distribute their high-end information.
To view today’s investor presentation, go to www.lifescienceintelligence.com and select EMT Spotlight and “register to attend.” The presentations will be archived on the LSI website. You can also call LSI at 1-714-847-3540.
